Call for Abstract
Scientific Program
3rd International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, will be organized around the theme “Novel Advances in Pharmaceutical R&D”
Pharmaceutica-2013 is comprised of 12 tracks and 59 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutica-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Sustained, controlled, and modulated drug delivery
- Track 1-2Reservoir and osmotic drug delivery system
- Track 1-3Polymeric drug delivery system
- Track 1-4Drug delivery devices
- Track 1-5Reservoir and osmotic drug delivery
- Track 1-6Polymeric drug delivery system
- Track 1-7 Drug delivery devices
- Track 2-1Challenges in pediatric and geriatric drug delivery
- Track 2-2Novel routes for insulin delivery
- Track 2-3Advances in oral and nasal drug delivery
- Track 2-4Developments in ophthalmic drug delivery systems
- Track 2-5Topical drug delivery system
- Track 2-6Parenterals and implants in drug delivery
- Track 2-7Suppositories as drug delivery systems
- Track 2-8Rectal and vaginal drug delivery
- Track 3-1Effect of route of administration and distribution on drug action
- Track 3-2Drug delivery systems: Entering the mainstream
- Track 3-3 In-vitro drug release characterization models
- Track 3-4Biomarkers in drug targeting and delivery
- Track 4-1 Discovery and development of biopharmaceuticals
- Track 4-2Dry biopharmaceuticals and applications
- Track 4-3Biopharmaceutical drugs from natural sources
- Track 4-4Formulation techniques for biopharmaceuticals
- Track 5-1Major issues in drug development and identifying the strategic market
- Track 5-2Pharmaceutical price controls and entry strategies
- Track 5-3Industry risk and market integration
- Track 6-1Nanotechnology in advanced drug delivery
- Track 6-2Impact of nanoscience and nanotechnology on controlled drug delivery
- Track 6-3Nanomaterials in drug delivery systems
- Track 6-4Efficacy of nanomaterials in drug targeting
- Track 6-5Application of nanobots in molecular drug delivery
- Track 6-6Advances in nano drugs for cancer chemotherapy
- Track 7-1Recent approaches in cancer
- Track 7-2Pharmacogenomics in personalized medicine
- Track 7-3Personalized medicine for central nervous system
- Track 7-4Personalized medicine for cardiovascular system
- Track 8-1Prodrugs and site-specific drug delivery
- Track 8-2Prodrugs in cancer chemotherapy
- Track 8-3Improved antiviral prodrugs
- Track 8-4Design of intramolecularly activated prodrugs
- Track 9-1Drug delivery to the brain through vascular route
- Track 9-2Local targets in brain for drug delivery
- Track 9-3Role of drug carriers in central nervous system
- Track 9-4Drug delivery through the blood-brain barrier
- Track 9-5Evolving strategies for effective brain drug delivery
- Track 10-1Recent progress in drug delivery systems for anticancer agents
- Track 10-2Combination drug formulations for the treatment of multidrug resistant tumors
- Track 10-3Molecular targeting of drug delivery systems to cancer
- Track 10-4Cancer biomarkers: Current issues and future directions
- Track 11-1Pharmacokinetics in drug design
- Track 11-2Pharmacokinetic behaviors of orally administered drugs
- Track 11-3In-silico drug discovery and development
- Track 11-4Computational methods in ADME and toxicity studies
- Track 11-5Pharmacokinetic parameters for drug input and drug disposition
- Track 11-6BA/BE studies of pharmacokinetic drug interactions
- Track 12-1Quality assurance and quality control guidelines
- Track 12-2The knowledge and skills of the successful QA/QC manager
- Track 12-3CGMP's for pharmaceutical products
- Track 12-4Regulatory requirements in NDA's